WiChR, a highly potassium-selective channelrhodopsin for low-light one- and two-photon inhibition of excitable cells

The electric excitability of muscle, heart, and brain tissue relies on the precise interplay of Na - and K -selective ion channels. The involved ion fluxes are controlled in optogenetic studies using light-gated channelrhodopsins (ChRs). While non-selective cation-conducting ChRs are well establishe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science advances 2022-12, Vol.8 (49), p.eadd7729
Hauptverfasser: Vierock, Johannes, Shiewer, Enrico, Grimm, Christiane, Rozenberg, Andrey, Chen, I-Wen, Tillert, Linda, Castro Scalise, Alejandro G, Casini, Marilù, Augustin, Sandra, Tanese, Dimitrii, Forget, Benoît C, Peyronnet, Rémi, Schneider-Warme, Franziska, Emiliani, Valentina, Béjà, Oded, Hegemann, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The electric excitability of muscle, heart, and brain tissue relies on the precise interplay of Na - and K -selective ion channels. The involved ion fluxes are controlled in optogenetic studies using light-gated channelrhodopsins (ChRs). While non-selective cation-conducting ChRs are well established for excitation, K -selective ChRs (KCRs) for efficient inhibition have only recently come into reach. Here, we report the molecular analysis of recently discovered KCRs from the stramenopile and identification of a novel type of hydrophobic K selectivity filter. Next, we demonstrate that the KCR signature motif is conserved in related stramenopile ChRs. Among them, WiChR from features a so far unmatched preference for K over Na , stable photocurrents under continuous illumination, and a prolonged open-state lifetime. Showing high expression levels in cardiac myocytes and neurons, WiChR allows single- and two-photon inhibition at low irradiance and reduced tissue heating. Therefore, we recommend WiChR as the long-awaited efficient and versatile optogenetic inhibitor.
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.add7729